Eliana Merle
Stock Analyst at Barclays
(3.47)
# 2,187
Out of 4,649 analysts
403
Total ratings
47.1%
Success rate
3.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eliana Merle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Maintained: Buy | $120 → $122 | $71.97 | +69.52% | 14 | Aug 14, 2026 | |
| ASND Ascendis Pharma | Maintained: Buy | $345 → $329 | $246.23 | +33.61% | 14 | Aug 14, 2026 | |
| ALT Altimmune | Maintained: Buy | $20 | $2.88 | +594.44% | 8 | Aug 13, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Buy | $157 | $81.21 | +93.33% | 20 | Aug 12, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $105 | $68.53 | +53.22% | 41 | Aug 10, 2026 | |
| INSM Insmed | Maintained: Buy | $237 | $126.33 | +87.60% | 8 | Aug 7, 2026 | |
| SRPT Sarepta Therapeutics | Maintained: Hold | $20 | $18.42 | +8.58% | 12 | Aug 7, 2026 | |
| RGNX REGENXBIO | Downgraded: Hold | $12 | $10.66 | +12.57% | 6 | Aug 7, 2026 | |
| SABS SAB Biotherapeutics | Maintained: Buy | $13 | $3.75 | +246.67% | 2 | Aug 7, 2026 | |
| MBX MBX Biosciences | Maintained: Buy | $70 → $88 | $67.08 | +31.19% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $133 → $139 | $114.42 | +21.48% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $917 | $805.97 | +13.78% | 5 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $615 → $617 | $516.44 | +19.47% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $43 | $26.38 | +63.00% | 6 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $48 | $63.65 | -24.59% | 31 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $527 → $450 | $227.12 | +98.13% | 16 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $964 → $962 | $507.37 | +89.61% | 15 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 | $55.87 | +61.09% | 22 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 → $60 | $47.06 | +27.50% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.28 | $0.1703 | +64.42% | 14 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $4.60 | +291.30% | 4 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $59 | $25.02 | +135.81% | 8 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $8 | $9.28 | -13.79% | 4 | Apr 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 | $11.65 | +183.26% | 1 | Jan 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $115 → $117 | $92.12 | +27.01% | 25 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $33 → $20 | $56.02 | n/a | 25 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $96 → $112 | $138.14 | n/a | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $63 → $12 | $85.59 | n/a | 3 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.41 | n/a | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $74 → $21 | $9.01 | n/a | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $2.2 | $4.15 | n/a | 6 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 | $202.00 | n/a | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $5 | $39.98 | n/a | 3 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $15.84 | n/a | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $8.72 | n/a | 3 | Mar 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $192 → $134 | $28.04 | n/a | 10 | Aug 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $1.85 | n/a | 8 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.68 | n/a | 4 | Mar 18, 2019 |
PTC Therapeutics
Aug 14, 2026
Maintained: Buy
Price Target: $120 → $122
Current: $71.97
Upside: +69.52%
Ascendis Pharma
Aug 14, 2026
Maintained: Buy
Price Target: $345 → $329
Current: $246.23
Upside: +33.61%
Altimmune
Aug 13, 2026
Maintained: Buy
Price Target: $20
Current: $2.88
Upside: +594.44%
BridgeBio Pharma
Aug 12, 2026
Maintained: Buy
Price Target: $157
Current: $81.21
Upside: +93.33%
BioMarin Pharmaceutical
Aug 10, 2026
Maintained: Buy
Price Target: $105
Current: $68.53
Upside: +53.22%
Insmed
Aug 7, 2026
Maintained: Buy
Price Target: $237
Current: $126.33
Upside: +87.60%
Sarepta Therapeutics
Aug 7, 2026
Maintained: Hold
Price Target: $20
Current: $18.42
Upside: +8.58%
REGENXBIO
Aug 7, 2026
Downgraded: Hold
Price Target: $12
Current: $10.66
Upside: +12.57%
SAB Biotherapeutics
Aug 7, 2026
Maintained: Buy
Price Target: $13
Current: $3.75
Upside: +246.67%
MBX Biosciences
Aug 7, 2026
Maintained: Buy
Price Target: $70 → $88
Current: $67.08
Upside: +31.19%
Aug 6, 2026
Maintained: Buy
Price Target: $133 → $139
Current: $114.42
Upside: +21.48%
Aug 5, 2026
Maintained: Buy
Price Target: $917
Current: $805.97
Upside: +13.78%
Aug 5, 2026
Maintained: Buy
Price Target: $615 → $617
Current: $516.44
Upside: +19.47%
Aug 5, 2026
Maintained: Buy
Price Target: $43
Current: $26.38
Upside: +63.00%
Aug 5, 2026
Maintained: Hold
Price Target: $48
Current: $63.65
Upside: -24.59%
Aug 3, 2026
Maintained: Buy
Price Target: $527 → $450
Current: $227.12
Upside: +98.13%
Aug 3, 2026
Maintained: Buy
Price Target: $964 → $962
Current: $507.37
Upside: +89.61%
Jul 30, 2026
Maintained: Buy
Price Target: $90
Current: $55.87
Upside: +61.09%
Jul 30, 2026
Maintained: Buy
Price Target: $65 → $60
Current: $47.06
Upside: +27.50%
Jul 28, 2026
Maintained: Sell
Price Target: $0.28
Current: $0.1703
Upside: +64.42%
Jun 4, 2026
Maintained: Buy
Price Target: $18
Current: $4.60
Upside: +291.30%
Jun 3, 2026
Maintained: Buy
Price Target: $59
Current: $25.02
Upside: +135.81%
Apr 2, 2026
Maintained: Hold
Price Target: $8
Current: $9.28
Upside: -13.79%
Jan 27, 2026
Maintained: Buy
Price Target: $33
Current: $11.65
Upside: +183.26%
Nov 6, 2025
Maintained: Hold
Price Target: $115 → $117
Current: $92.12
Upside: +27.01%
Aug 12, 2025
Maintained: Hold
Price Target: $33 → $20
Current: $56.02
Upside: n/a
Aug 8, 2025
Maintained: Hold
Price Target: $96 → $112
Current: $138.14
Upside: n/a
Jul 21, 2025
Downgraded: Hold
Price Target: $63 → $12
Current: $85.59
Upside: n/a
Jul 15, 2025
Maintained: Buy
Price Target: $8
Current: $1.41
Upside: n/a
May 15, 2025
Maintained: Buy
Price Target: $74 → $21
Current: $9.01
Upside: n/a
Jan 28, 2025
Maintained: Hold
Price Target: $5 → $2.2
Current: $4.15
Upside: n/a
Jan 8, 2025
Maintained: Buy
Price Target: $71
Current: $202.00
Upside: n/a
Apr 4, 2024
Maintained: Hold
Price Target: $3 → $5
Current: $39.98
Upside: n/a
Oct 13, 2022
Initiated Coverage: Buy
Price Target: $22
Current: $15.84
Upside: n/a
Mar 3, 2021
Reiterated: Buy
Price Target: $10
Current: $8.72
Upside: n/a
Aug 19, 2020
Maintained: Hold
Price Target: $192 → $134
Current: $28.04
Upside: n/a
Dec 11, 2019
Maintained: Buy
Price Target: $40
Current: $1.85
Upside: n/a
Mar 18, 2019
Reiterated: Buy
Price Target: $8
Current: $4.68
Upside: n/a